Gilead Sciences, Inc. (GILD) analyst actions
Rating and price-target actions on GILD in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the GILD overview →
2 measured GILD analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Gilead Sciences, Inc. (GILD) And Encourages Shareholders to Reach Out | Press release | +0.31% | +2.35% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Gilead Sciences, Inc. (GILD) And Encourages Stockholders to Reach Out | Press release | -0.23% | +2.06% |
Keep exploring
More GILD: earnings → · SEC filings → · GILD overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Marinus Pharmaceuticals, Inc. (MRNS) | 687 | 0.00% | 50% |
| PTC Therapeutics, Inc. (PTCT) | 686 | +0.01% | 50% |
| ONCOMED PHARMACEUTICALS (OMED) | 677 | -0.20% | 44% |
| ARATANA THERAPEUTICS (PETX) | 677 | 0.00% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.